<DOC>
	<DOCNO>NCT02365142</DOCNO>
	<brief_summary>Purpose : To determine safety , feasibility effectiveness ( clinical radiological ) intra-articular administration autologous mesenchymal stem cell ( MSCs ) platelet richa plasma ( PRGF ) patient knee osteoarthritis . Patients method Clinical trial phase I- II , randomize , multicenter , two treatment arm 19 patient group . The investigator compare intraarticular injection administration two different dos mesenchymal stem cell hialuronic acid accord follow scheme : 1 . Group A : 3 intra-articular injection platelet rich plasma ( PRGF® ) separate 7 day . 2 . Group B : 3 intra-articular injection platelet richa plasma ( PRGF® ) separate 7 day one Mesenchimal stem cell . Intra-articular injection 100 million autologous mesenchymal progenitor stem cell culture ex - vivo ( cell suspension sterile small volume ( 5-10 ml ) vehicle suitable intraarticular injection ) follow intraarticular injection platelet richa plasma ( PRGF® ) . The treatment complete 2 injection platelet richa plasma ( PRGF® ) separeted one week . In addition investigator assess response intra-articular infusion CMM analyze follow parameter : - Clinical assessment pain function ( Baseline , 1 , 3 , 6 12 month since treatment ) : VAS , WOMAC , KOOS , EuroQol , SF-16 , Lequesne , WOMAC , KOOS . - Radiographic ( baseline 12 month treatment ) : Femorotibial space . - Radiographic use MRI ( baseline 12 month treatment ) : assess number location lesion , cartilage thickness , signal intensity , subchondral bone alteration , volume WORMS dGEMRIC protocol .</brief_summary>
	<brief_title>Treatment Osteoarthritis Intra-articular Injection Bone Marrow Mesenchymal Stem Cells With Platelet Rich Plasma</brief_title>
	<detailed_description>Purpose : To determine safety , feasibility effectiveness ( clinical radiological ) intra-articular administration autologous mesenchymal stem cell ( MSCs ) platelet richa plasma ( PRGF® ) patient knee osteoarthritis . Patients method Clinical trial phase I- II , randomize , multicenter , two treatment arm 19 patient group . The investigator compare intraarticular injection administration two different dos mesenchymal stem cell hialuronic acid accord follow scheme : 1 . Group A : 3 intra-articular injection platelet richa plasma ( PRGF® ) separate 7 day . 2 . Group B : 3 intra-articular injection platelet richa plasma ( PRGF® ) separate 7 day one Mesenchimal stem cell . Intra-articular injection 100 million autologous mesenchymal progenitor stem cell culture ex - vivo ( cell suspension sterile small volume ( 5-10 ml ) vehicle suitable intraarticular injection ) follow intraarticular injection platelet richa plasma ( PRGF® ) . The treatment complete 2 injection platelet richa plasma ( PRGF® ) separeted one week . The autologous mesenchymal stem cell obtain iliac crest local anesthesia sedation . They culture ex vivo The primary endpoint safety feasibility . The investigator register occurrence complication / adverse effect study . In addition investigator assess response intra-articular infusion CMM analyze follow parameter : - Clinical assessment pain function ( Baseline , 1 , 3 , 6 12 month since treatment ) : VAS , WOMAC , KOOS , EuroQol , SF-16 , Lequesne , WOMAC , KOOS . - Radiographic ( baseline , 6 12 month since treatment ) : Femorotibial space . - Radiographic use MRI ( baseline , 6 12 month since treatment ) : assess number location lesion , cartilage thickness , signal intensity , subchondral bone alteration , volume WORMS dGEMRIC protocol . All patient meet follow inclusion exclusion criterion :</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Males females 40 80 year old Bad result previous hyaluronic acid injection Diagnosis knee OA accord criterion osteoarthritis ACR ( American College Rheumatology ) Joint pain equal great 2.5 point visual analogue scale ( VAS ) Radiological Classification : KellgrenLawrence scale great equal 2 Body mass index 20 35 kg/m2 Ability follow study period Bilateral Osteoarthritis Knee require treatment knee Previous diagnosis polyarticular disease Severe mechanical deformation Arthroscopy previous 6 month Intraarticular infiltration hyaluronic acid last 6 month Systemic autoimmune rheumatic disease Poorly control diabetes mellitus Blood dyscrasia Immunosuppressive anticoagulant treatment Treatment corticosteroid 3 month prior inclusion study NSAID therapy within 15 day prior inclusion study Patients history allergy penicillin streptomycin</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Knee Osteoarthritis</keyword>
	<keyword>Mesenchimal stem cell</keyword>
	<keyword>Osteoarthritis</keyword>
</DOC>